11/15/2024 9:35 AM | Marinus Pharmaceuticals (Subject) PRUDENTIAL FINANCIAL INC (Filed by) PRUDENTIAL FINANCIAL INC (Filed by)
| Form SC 13G/A | |
11/15/2024 7:00 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 5:39 PM | Marinus Pharmaceuticals (Subject) Sofinnova Investments, Inc. (Filed by)
| Form SC 13G | |
11/14/2024 2:04 PM | Cormorant Asset Management, LP (Filed by) Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/14/2024 11:24 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by) Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/14/2024 8:34 AM | Avoro Capital Advisors LLC (Filed by) Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/12/2024 8:55 AM | JENNISON ASSOCIATES LLC (Filed by) Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
|
11/01/2024 7:30 PM | Marinus Pharmaceuticals (Subject) Panacea Innovation Ltd (Filed by)
| Form SC 13G | |
10/31/2024 12:05 PM | FRANKLIN RESOURCES INC (Filed by) Marinus Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
10/24/2024 7:05 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/15/2024 6:57 AM | Marinus Pharmaceuticals (Issuer) MAYLEBEN TIMOTHY M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/02/2024 6:56 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/20/2024 7:15 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/13/2024 7:00 AM | Marinus Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024 6:09 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/20/2024 3:27 PM | Marinus Pharmaceuticals (Issuer) Noonberg Sarah B. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 3:27 PM | Marinus Pharmaceuticals (Issuer) Silverstein Christine Berni (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 3:20 PM | Braunstein Scott (Reporting) Marinus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 3:21 PM | Marinus Pharmaceuticals (Issuer) Pfanstiel Steven (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 3:21 PM | Hulihan Joseph (Reporting) Marinus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 3:21 PM | MANNING MARTHA E (Reporting) Marinus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 3:22 PM | Marinus Pharmaceuticals (Issuer) Shafer Christina (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 3:23 PM | Austin Charles (Reporting) Marinus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 3:23 PM | Ezickson Elan (Reporting) Marinus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 6:01 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/06/2024 3:55 PM | Marinus Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/24/2024 5:35 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/17/2024 6:05 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2024 6:05 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2024 6:07 AM | Marinus Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024 4:51 PM | CITADEL ADVISORS LLC (Filed by) Marinus Pharmaceuticals (Subject)
| Form SC 13G | |
04/19/2024 5:04 AM | Marinus Pharmaceuticals (Subject) TANG CAPITAL PARTNERS LP (Filed by)
| Form SC 13G | |
04/15/2024 6:32 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/04/2024 7:00 AM | Marinus Pharmaceuticals (Filer)
| Form DEF 14A | |
04/04/2024 7:02 AM | Marinus Pharmaceuticals (Filer)
| Form DEFA14A | |
03/27/2024 10:55 AM | Braunstein Scott (Reporting) Marinus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 11:18 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by) Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024 9:35 AM | Marinus Pharmaceuticals (Subject) PRUDENTIAL FINANCIAL INC (Filed by) PRUDENTIAL FINANCIAL INC (Filed by)
| Form SC 13G | |
02/14/2024 8:04 AM | Avoro Capital Advisors LLC (Filed by) Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/13/2024 11:13 AM | Marinus Pharmaceuticals (Subject) SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/08/2024 12:56 PM | JENNISON ASSOCIATES LLC (Filed by) Marinus Pharmaceuticals (Subject)
| Form SC 13G | |
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad) As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential.
Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now! |
02/07/2024 6:25 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/06/2024 10:58 AM | FRANKLIN RESOURCES INC (Filed by) Marinus Pharmaceuticals (Subject)
| Form SC 13G | |
01/19/2024 3:18 PM | Braunstein Scott (Reporting) Marinus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:19 PM | Marinus Pharmaceuticals (Issuer) Pfanstiel Steven (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:20 PM | Hulihan Joseph (Reporting) Marinus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:21 PM | MANNING MARTHA E (Reporting) Marinus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:21 PM | Marinus Pharmaceuticals (Issuer) Shafer Christina (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:22 PM | Marinus Pharmaceuticals (Issuer) MAYLEBEN TIMOTHY M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:23 PM | Austin Charles (Reporting) Marinus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:23 PM | Marinus Pharmaceuticals (Issuer) Nochur Sara (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:25 PM | Fischer Seth H. Z. (Reporting) Marinus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:26 PM | Ezickson Elan (Reporting) Marinus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:27 PM | Marinus Pharmaceuticals (Issuer) Silverstein Christine Berni (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:27 PM | Johnson Marvin (Reporting) Marinus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:28 PM | Marinus Pharmaceuticals (Issuer) Noonberg Sarah B. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 6:04 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/28/2023 6:05 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |